Table 1.

Baseline demographics and characteristics of 521 Caucasian patients

Covariates	Caucasians n = 521
Age, years	63±14
Female sex, n (%)	178 (34.2)
BMI, kg/m2*	27±5
Previous history of AMI, n (%)	117 (22.5)
Previous history of PCI/CABG, n (%)	144 (27.6)
ST elevation, n (%)	209 (40.1)
In-hospital events
In hospital ventricular tachycardia/fibrillation, n (%)	70 (13.4)
In hospital PCI, n (%)	372 (71.4)
In hospital CABG, n (%)	46 (8.8)
In hospital thrombolysis, n (%)	26 (5.0)
In hospital defibrillation, n (%)	38 (7.3)
In-hospital Chemistry/Hematology
Creatinine, mg/dl	1.2±0.9
Peak troponin I, µg/l*	42.2±155.6
Peak troponin T, µg/l†	2.0±2.6
Peak CK-MB, U/L‡	102.8±142.7
Medication Use In-hospital
Diuretics, n (%)	222 (42.6)
Beta blockers, n (%)	464 (89.1)
ACE Inhibitors, n (%)	363 (69.7)
Statins, n (%)	443 (85.0)
Aspirin, n (%)	496 (95.2)

^*328 of 521 patients had troponin I values;

^†130 of 521 patients had troponin T values

^‡510 of 521 patients had CKMB values.